Product Information
CHOLESTYRAMINE POWDER is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.0924 per GM under NDC 27241013451. Its NADAC has been published 200 times since Sep 14, 2022.
FDA first approved this application on Apr 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/9g
Manufacturer
Ajanta Pharma USA Inc.NDC
27241013451
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211119FDA Approved
4/6/2020
TE Code
AB
On Market Since
4/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE POWDER has been published 200 times since Sep 14, 2022, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0924 per GM |
|---|---|
| All-time high | $0.1551 (Nov 16, 2022) |
| All-time low | $0.0789 (Nov 20, 2024) |
| 52-week high | $0.0977 |
| 52-week low | $0.0870 |
| Median price | $0.1062 |
| Average price | $0.1098 |
| Largest weekly change | +61.2% (May 22, 2024) |
| Weeks tracked | 200 |
| Tracking since | Sep 14, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cholestyramine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE POWDER?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE POWDER, manufactured by Ajanta Pharma USA Inc., is $0.0924 per GM (NDC 27241013451), effective Sep 30, 2026.
How has the price of CHOLESTYRAMINE POWDER changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE POWDER has declined 37.2%. It has been tracked across 200 weekly CMS publications since Sep 14, 2022.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE POWDER?
Since Sep 14, 2022, the NADAC for CHOLESTYRAMINE POWDER has ranged from a low of $0.0789 (Nov 20, 2024) to a high of $0.1551 (Nov 16, 2022), with a median of $0.1062 per GM.
Are there cheaper alternatives to CHOLESTYRAMINE POWDER?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHOLESTYRAMINE POWDER in a comparable dosage form, but none are currently priced below it.
Who manufactures CHOLESTYRAMINE POWDER?
CHOLESTYRAMINE POWDER (NDC 27241013451) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.